Northwestern University Fienberg School of Medicine

Chicago, Illinois 60611

We've found

1 trials

at this facility

A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL

Status: Enrolling, Phase III
Updated: 7/17/2014

from

Chicago, IL

Use our guide to learn which trials are right for you!